Genetic Determinants of Variability in Warfarin Response after the Dose-Titration Phase

OBJECTIVES: Genetic factors contribute substantially to variability in warfarin dose requirements and are important in the dose-titration phase; their effects on the stability of anticoagulation later in therapy are not known. METHODS: Using de-identified electronic medical records linked to a DNA-b...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pharmacogenet Genomics
Prif Awduron: Iwuchukwu, Otito F, Ramirez, Andrea H, Shi, Yaping, Bowton, Erica A, Kawai, Vivian K, Schildcrout, Jonathan S, Roden, Dan M, Denny, Joshua C, Stein, C. Michael
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5300764/
https://ncbi.nlm.nih.gov/pubmed/27632229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000244
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg